Scale Venture Partners II, LP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Scale Venture Partners II, LP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Scale Venture Partners II, LP. Scale Venture Partners II, LP is a 10% Owner in Orexigen Therapeutics, Inc. ($OREX).

Address: 950 TOWER LANE, SUITE 700 FOSTER CITY 94404 CA

Companies in which Scale Venture Partners II, LP is an Insider

Orexigen Therapeutics, Inc.

Trading Symbol: OREX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scale Venture Partners II, LP: 10% Owner
Holdings: 2,717,445 shares
Current Value: $12,445,898
Latest Transaction: Nov 21 2007
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Scale Venture Partners II, LP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 21 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.001001,5002,717,4452.7 M to 2.7 M (0.00 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.006009,0002,717,5452.7 M to 2.7 M (-0.02 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.041001,5042,718,1452.7 M to 2.7 M (0.00 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.171001,5172,718,2452.7 M to 2.7 M (0.00 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.10142112,718,3452.7 M to 2.7 M (0.00 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.131862,8142,718,3592.7 M to 2.7 M (-0.01 %)
Nov 20 2007OREXOrexigen Therapeut ...Scale Venture Partners II, LP10% OwnerSellS15.011,00015,0102,718,5452.7 M to 2.7 M (-0.04 %)

View all Scale Venture Partners II, LP insider transactions.